학술논문
Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: a real-world analysis
Document Type
Short Communication
Author
Source
In Blood Advances 13 February 2024 8(3):549-552
Subject
Language
ISSN
2473-9529